Kimberly Banks MacKay

Insider Reports History

Location
Exton, PA
Signature
/s/ Debra S. Rouse, attorney-in-fact for Kimberly Banks MacKay
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kimberly Banks MacKay:

Company Role Class Num Shares Value Price $ Report Date Ownership
WEST PHARMACEUTICAL SERVICES INC SVP, GC & Corporate Secretary Stock Option (Right to Buy) 1,162 $457,061 $393.34 18 Feb 2025 Direct
WEST PHARMACEUTICAL SERVICES INC SVP, GC & Corporate Secretary Common Stock 1,512 $319,018 $211.00 18 Feb 2025 Direct
CTS CORP Director Common 3,500 $139,790 $39.94 06 Nov 2025 Direct
WEST PHARMACEUTICAL SERVICES INC SVP, GC & Corporate Secretary Rst. Stock Unit 503 $106,133 $211.00 18 Feb 2025 Direct

Insider Reports Filed by Kimberly Banks MacKay

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CTS CTS CORP 06 Nov 2025 0 $0 3 Director 10 Nov 2025, 16:06
WST WEST PHARMACEUTICAL SERVICES INC 18 Feb 2025 4 +$32,382 4 SVP, GC & Corporate Secretary 20 Feb 2025, 21:13
WST WEST PHARMACEUTICAL SERVICES INC 20 Feb 2024 2 $0 4 SVP, GC & Corporate Secretary 22 Feb 2024, 18:29
WST WEST PHARMACEUTICAL SERVICES INC 21 Feb 2023 2 +$100,284 4 SVP, GC & Corporate Secretary 23 Feb 2023, 17:27
WST WEST PHARMACEUTICAL SERVICES INC 22 Feb 2022 1 +$114,430 4 SVP, GC & Corporate Secretary 24 Feb 2022, 17:59
WST WEST PHARMACEUTICAL SERVICES INC 22 Feb 2022 1 $0 4 SVP, GC & Corporate Secretary 24 Feb 2022, 15:55